Disulfonate stilbenes for use in the treatment of proliferative diseases

A method of treatment of a cancer in a subject in need thereof, wherein the method comprises a step of administration to the subject of a compound of Formula (I)

• wherein:
• R0A and R0B are independently selected from the group consisting of hydrogen, lithium, sodium, and potassium;
• and
• RA and RB are identical and selected from the group consisting of —NH—COOR, azido, cyano, and halide;
• wherein each R is independently selected from the group consisting of (C1-C4)-alkyl and phenyl;
• wherein the phenyl is optionally substituted by one or two substituent(s) independently selected from the group consisting of (C1-C3)-alkyl, (C1-C3)-alkoxy, and nitro;
• or a pharmaceutically acceptable salt thereof.